Novel glitazones: Design, synthesis, glucose uptake and structure-activity relationships

被引：42

作者：

Kumar, B. R. Prashantha ^{[2
]}

Nanjan, M. J. ^{[1
]}

机构：

[1] JSS Coll Pharm, TIFAC CORE, Ootacamund 643001, Tamil Nadu, India

[2] JSS Coll Pharm, Dept Pharmaceut Chem, Ootacamund 643001, Tamil Nadu, India

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 06期

关键词：

Glitazones; Glucose uptake; Diabetes; PPAR-gamma; Antidiabetic activity; PROLIFERATOR-ACTIVATED RECEPTORS; LIGANDS; AGENTS;

D O I：

10.1016/j.bmcl.2010.01.125

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Glitazones are known to exhibit antihyperglycemic activity by decreasing peripheral insulin resistance. In the present study, we have designed some novel glitazones based on the structure-activity relationships as possible PPAR-gamma agonists. The manually designed glitazones were synthesized by using the appropriate synthetic schemes and screened for their in vitro antihyperglycemic activity by estimating glucose uptake by rat hemi-diaphragm, both in the absence and in the presence of external insulin. Some of the glitazones exhibited good antihyperglycemic activity in presence of insulin. Illustration about their design, synthesis, evaluation, and structure-activity relationships is described. (C) 2010 Elsevier Ltd. All rights reserved.

引用

页码：1953 / 1956

页数：4

共 50 条

[21] Novel Ligands for human melanocortin receptor subtypes: Design, synthesis and structure-activity relationships
Stankova, Magda
Cai, Minying
Cabello, Chris
DeCot, Bridgette
Krchnak, Victor, Jr.
Hruby, Victor J.
PEPTIDE REVOLUTION: GENOMICS, PROTEOMICS & THERAPEUTICS, 2004, : 649 - 650
[22] Design, synthesis, and structure-activity relationships of novel insulin receptor tyrosine kinase activators
Lum, Robert T.
Cheng, Mingshan
Cristobal, Cristina P.
Goldfine, Ira D.
Evans, Joseph L.
Keck, James G.
Macsata, Robert W.
Manchem, Vara Prasad
Matsumoto, Yukiharu
Park, Sophia J.
Rao, Sandhya S.
Robinson, Louise
Shi, Songyuan
Spevak, Wayne R.
Schow, Steven R.
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (19) : 6173 - 6187
[23] Novel ligands for human melanocortin receptor subtypes: Design, synthesis and structure-activity relationships
Stankova, M
Cai, M
Cabello, C
DeCot, B
Krchnak, V
Hruby, VJ
BIOPOLYMERS, 2003, 71 (03) : 309 - 309
[24] Synthesis and insecticidal structure-activity relationships of novel tonghaosu analogs
Yin, BL
Chen, L
Xu, HH
Hu, TS
Wu, YL
CHINESE JOURNAL OF CHEMISTRY, 2006, 24 (02) : 240 - 246
[25] Synthesis of novel aminoglycosides and the study of structure-activity relationships.
Elchert, B
Chang, CWT
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U175 - U175
[26] Synthesis and structure-activity relationships of some novel oxetane carbapenems
Sakya, SM
Strohmeyer, TW
Bitha, P
Lang, SA
Lin, YI
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (14) : 1805 - 1810
[27] Synthesis and novel structure-activity relationships of potent sansalvamide A derivatives
Otrubova, K
Styers, TJ
Pan, PS
Rodriguez, R
McGuire, KL
McAlpine, SR
CHEMICAL COMMUNICATIONS, 2006, (09) : 1033 - 1034
[28] Synthesis and structure-activity relationships of novel desmycosin ketolides.
Pavlovic, D
Narandja, A
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U681 - U681
[29] Synthesis and structure-activity relationships of novel benzofuran farnesyltransferase inhibitors
Asoh, Kohsuke
Kohchi, Masami
Hyoudoh, Ikumi
Ohtsuka, Tatsuo
Masubuchi, Miyako
Kawasaki, Kenichi
Ebiike, Hirosato
Shiratori, Yasuhiko
Fukami, Takaaki A.
Kondoh, Osamu
Tsukaguchi, Toshiyuki
Ishii, Nobuya
Aoki, Yuko
Shimma, Nobuo
Sakaitani, Masahiro
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (06) : 1753 - 1757
[30] Overcoming Chloroquine Resistance in Malaria: Design, Synthesis, and Structure-Activity Relationships of Novel Hybrid Compounds
Boudhar, Aicha
Ng, Xiao Wei
Loh, Chiew Yee
Chia, Wan Ni
Tan, Zhi Ming
Nosten, Francois
Dymock, Brian W.
Tan, Kevin S. W.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (05) : 3076 - 3089

← 1 2 3 4 5 →